GMED vs GKOS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GMED · Globus Medical$71.05 ▼ 12.76%
GKOS · Glaukos$224.41 ▲ 2.01%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GMED -17.7%
- GKOS +154.0%
Head to head
| Metric | GMED | GKOS |
|---|---|---|
| Price | $71.05 | $224.41 |
| Change today | ▼ 12.76% | ▲ 2.01% |
| Market cap | $9.41B | $13.28B |
| Return, 3 months | -17.5% | +23.7% |
| Return, year to date | -18.6% | +98.8% |
| Return, 1 year | -15.3% | +167.6% |
| P/E (TTM) | 17.5 | – |
| P/B | 2.0 | 18.5 |
| P/E percentile vs own 5y | 7th | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.9% | +58.0% |
| Net profit growth (YoY) | -25.3% | +112.4% |
| Gross margin | 68.5% | 64.8% |
| Operating margin | 21.4% | -25.3% |
| Net margin | 17.0% | -24.6% |
| Return on equity | 11.8% | -22.8% |
| Analyst target vs. price | +41.1% | +5.8% |
| Analyst buy share | 75% | 100% |
| RSI (14) | 39 | 64 |
| 30-day volatility | 61.7% | 98.5% |
| Max drawdown, 1 year | -26.6% | -28.4% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- GKOS is the largest of the group by market value.
- GKOS has returned the most over the past year.
- GKOS is growing revenue fastest.
- GMED keeps the most profit per dollar of sales.
- GMED has been the calmest stock over the last 30 days.